NCT03216486 An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Status WITHDRAWN Phase PHASE2
NCT03208582 Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta? Status COMPLETED Phase PHASE2
NCT03064074 Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta Status COMPLETED Phase PHASE1
NCT03029312 Whole Body Vibration Training in Children With Osteogenesis Imperfecta and Limited Mobility Status COMPLETED Phase NA
NCT02934451 Dental Malocclusion and Craniofacial Development in OI Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02814591 Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy Status UNKNOWN Phase N/A
NCT02793063 Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2 Status COMPLETED Phase N/A
NCT02542540 Effects of a Physical Rehabilitation Program Using the Nintendo Wii on Children With Osteogenesis Imperfecta (OI) Status TERMINATED Phase NA
NCT02352753 Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI Status TERMINATED Phase PHASE3
NCT02303873 Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta Status COMPLETED Phase PHASE4
NCT02172885 Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta Status COMPLETED Phase PHASE1
NCT01799798 Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab Status COMPLETED Phase PHASE2
NCT01713231 Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta Status COMPLETED Phase PHASE4
NCT01679080 The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta Status TERMINATED Phase PHASE2
NCT01417091 Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta Status COMPLETED Phase PHASE2
NCT00982124 An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta Status COMPLETED Phase PHASE3